Glooko Inc., a Palo Alto, Calif.-based platform for diabetes management, raised $16.5m in Series B funding.
The round was co-led by Canaan Partners and Medtronic with participation from existing investors The Social + Capital Partnership and Samsung. As part of this round, Canaan Partners’ Wende Hutton joined Glooko’s Board of Directors.
The company will use the funds to continue to develop the platform and expand operations.
Co-founded in June 2010 by Yogen Dalal, Sundeep Madra and Chamath Palihapitiya, Glooko provides a unified management system that allows patients, and the providers and payers that care for them, to manage their diabetes.
The system is FDA 510(k) cleared and HIPAA compliant. With the mobile app and Glooko MeterSync Cable, patients can download meter readings from a multitude of FDA-cleared glucose meters into their device. This data is accessible, annotatable, and sharable.